Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06722183
Title A Phase II Platform Trial of Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities (FUTURE)
Acronym FUTURE
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Klinikum St. Marien Amberg Amberg Germany Details
Charité Campus Virchow Klinikum (CVK) Berlin Germany Details
Universitätsklinikum Düsseldorf Düsseldorf Germany Details
Kliniken Essen-Mitte Essen Germany Details
Krankenhaus Nordwest Frankfurt am Main 60488 Germany Details
Hope Hamburg Hamburg Germany Details
Universitätsmedizin Mainz Mainz Germany Details
Klinikum München rechts der Isar München Germany Details
MVZ für Hämatologie und Onkologie Ravensburg GmbH Ravensburg 88212 Germany Details
Leopoldina Krankenhaus Schweinfurt Schweinfurt Germany Details
Universitätsklinikum Ulm Ulm Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field